Dr. Pritt Verma completed Ph.D. in Pharmaceutical Sciences (Pharmacology) jointly from Department of Pharmacology CSIR-National Botanical Research Institute and Amity Institute of Pharmacy, Amity University Uttar Pradesh, Lucknow Campus Lucknow, India, with a focus to the ethno medicinal value of medicinal plants in hepatotoxicity with a keen interest in molecular biology (In-vitro study) on cell lines. She was involved to evaluate the antiulcer activity of the medicinal plants using pylorus ligation, paracetamol, and indomethacin-induced ulcer model. She is Graduate member of The American Society of Pharmacology and Experimental Therapeutics, Member of International Society of Ethno pharmacology UK, Life time member of National Society of Ethno pharmacology, Kolkata, India with interest in evolution and application of sophisticated and modern technologies in early diagnosis and treatment of different liver fibrosis and liver toxicity; from lung cancers to pulmonary hypertension, lung disease and development of some novel pathway related to reducing the liver fibrosis.
Dr. Pritt Verma, working on pharmacological screening of drugs/medicinal plant on rodents focused to hepatotoxicity, Preclinical Toxicological Evaluation, (As per OECD guidelines), Anti Inflammatory, Analgesic activity, Hepatotoxicity, Anti-diabetic and Anti-ulcer study. After her Ph.D. Dr. Pritt's preclinical expertise is in instrumental in setting up of liver fibrosis disease study from phytomolecules, an evolving sub specialty of isolation of phytoconstituents from the plant using various bio fractions and metabolomics study to identify the compounds for biological activity and development of the new drug. This field focuses on the isolation of compounds from medicinal plants having the potential value in the cure of disease and to find the new pathway to reduce the liver toxicity. She also performed advanced screening and surgical procedures on rats with inducing agents followed by the treated group as per the protocol. Other molecular biology studies include biochemical parameters, oxidative stress parameters, and some molecular pharmacology study of interleukins and cytokines, Western blotting, ELISA, Immunohistochemistry, Mammalian cell culture, and preclinical study include the development of different mouse models of asthma. She was actively involved and developed the Herbal cigarette for smokers to reduce the pulmonary disease. She is an expert in Oral/Intratracheal/Intravenous/Intranasal drug administration in mice/rat, ligation of capillaries like arteries/veins/bile-duct/trachea/pylorus in the rat; she has expertise in the study of the mechanism of liver fibrosis using cell lines and In-vivo study on rats. She studied the role of antioxidants. Interleukins and cytokines on liver toxicity. The outcome of my research studies in hepatotoxicity, liver fibrosis, antiulcer and pulmonary hypertension has been published in reputed journals and presented in multiple national and international conferences.